Analysis of CYP27B1, encoding 25-hydroxyvitamin D-1α-hydroxylase, as a candidate tumor suppressor gene in primary and severe secondary/tertiary hyperparathyroidism

Journal of Bone and Mineral Research

Volumn 24, Issue 1, 2009, Pages 102-104

  Lauter, Kelly ^a   Arnold, Andrew ^a,b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Parathyroid; PTH; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; 25 HYDROXYVITAMIN D1 ALPHA HYDROXYLASE; CALCITRIOL; CYTOCHROME P450; CYTOCHROME P450 CYP27B1; UNCLASSIFIED DRUG;

25 HYDROXYVITAMIN D 1ALPHA HYDROXYLASE GENE; ARTICLE; CARCINOGENICITY; CELL GROWTH; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC CODE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; HYPERPARATHYROIDISM; MAJOR CLINICAL STUDY; PARATHYROID ADENOMA; PARATHYROID GLAND; PARATHYROID TUMOR; PRIMARY HYPERPARATHYROIDISM; SECONDARY HYPERPARATHYROIDISM; TERTIARY HYPERPARATHYROIDISM; TUMOR SUPPRESSOR GENE;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ADENOMA; BINDING SITES; EXONS; GENES, TUMOR SUPPRESSOR; HUMANS; HYPERPARATHYROIDISM; MODELS, GENETIC; MUTATION; PARATHYROID NEOPLASMS; POLYMERASE CHAIN REACTION; RECEPTORS, CALCITRIOL; SEQUENCE ANALYSIS, DNA;

EID: 58149085877     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.080903     Document Type: Article

References (21)

1. Silver J, Levi R 2005 Regulation of PTH synthesis and secretion relevant to the management of secondary hyperparathyroidism in chronic kidney disease. Kidney Int 67(Suppl 95):S8-S12.
2. Silver J, Naveh-Many T, Mayer H, Schmelzer HJ, Popovtzer MM 1986 Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J Clin Invest 78:1296-1301.
3. Kim CJ, Kaplan LE, Perwad F, Huang N, Sharma A, Choi Y, Miller WL, Portale AA 2007 Vitamin D 1alpha-hydroxylase gene mutations in patients with 1alpha-hydroxylase deficiency. J Clin Endocrinol Metab 92:3177-3182.
4. St-Arnaud R, Messerlian S, Moir JM, Omdahl JL, Glorieux FH 1997 The 25-hydroxyvitamin D 1-alpha-hydroxylase gene maps to the pseudovitamin D-deficiency rickets (PDDR) disease locus. J Bone Miner Res 12:1552-1559.
5. Panda DK, Miao D, Tremblay ML, Sirois J, Farookhi R, Hendy GN, Goltzman D 2001 Targeted ablation of the 25-hydroxyvitamin D 1alpha-hydroxylase enzyme: Evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci USA 98:7498-7503.
6. Dardenne O, Prud'homme J, Glorieux FH, St-Arnaud R 2004 Rescue of the phenotype of CYP27B1 (1alpha-hydroxylase)-deficient mice. J Steroid Biochem Mol Biol 89-90:327-330.
7. Zehnder D, Bland R, Walker EA, Bradwell AR, Howie AJ, Hewison M, Stewart PM 1999 Expression of 25-hydroxyvitamin D3-1alpha-hydroxylase in the human kidney. J Am Soc Nephrol 10:2465-2473.
8. Segersten U, Correa P, Hewison M, Hellman P, Dralle H, Carling T, Akerstrom G, Westin G 2002 25-hydroxyvitamin D(3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands. J Clin Endocrinol Metab 87:2967-2972.
9. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, Hewison M 2001 Extrarenal expression of 25-hydroxyvitamin d(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 86:888-894.
10. Arnold A, Staunton CE, Kim HG, Gaz RD, Kronenberg HM 1988 Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas. N Engl J Med 318:658-662.
11. Arnold A, Brown MF, Urena P, Gaz RD, Sarfati E, Drueke TB 1995 Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 95:2047-2053.
12. Haber D, Harlow E 1997 Tumour-suppressor genes: Evolving definitions in the genomic age. Nat Genet 16:320-322.
13. Heppner C, Kester MB, Agarwal SK, Debelenko LV, Emmert-Buck MR, Guru SC, Manickam P, Olufemi SE, Skarulis MC, Doppman JL, Alexander RH, Kim YS, Saggar SK, Lubensky IA, Zhuang Z, Liotta LA, Chandrasekharappa SC, Collins FS, Spiegel AM, Burns AL, Marx SJ 1997 Somatic mutation of the MEN1 gene in parathyroid tumours. Nat Genet 16:375-378.
14. Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J, Simonds WF, Gillanders EM, Kennedy AM, Chen JD, Agarwal SK, Sood R, Jones MP, Moses TY, Haven C, Petillo D, Leotlela PD, Harding B, Cameron D, Pannett AA, Hoog A, Heath H III, James-Newton LA, Robinson B, Zarbo RJ, Cavaco BM, Wassif W, Perrier ND, Rosen IB, Kristoffersson U, Turnpenny PD, Farnebo LO, Besser GM, Jackson CE, Morreau H, Trent JM, Thakker RV, Marx SJ, Teh BT, Larsson C, Hobbs MR 2002 HRP12, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 32:676-680.
15. Fearon E 1999 Tumor suppressor genes, In: Vogelslein B, Kinzler KW (eds.) The Genetic Basis of Human Cancer, 2nd ed., vol. 6. McGraw Hill, New York, NY, USA, pp. 233-234.
16. Imanishi Y, Tahara H, Palanisamy N, Spitalny S, Salusky IB, Goodman W, Brandi ML, Drueke TB, Sarfati E, Urena P, Chaganti RS, Arnold A 2002 Clonal chromosomal defects in the molecular pathogenesis of refractory hyperparathyroidism of uremia. J Am Soc Nephrol 13:1490-1498.
17. Palanisamy N, Imanishi Y, Rao PH, Tahara H, Chaganti RS, Arnold A 1998 Novel chromosomal abnormalities identified by comparative genomic hybridization in parathyroid adenomas. J Clin Endocrinol Metab 83:1766-1770.
18. Brown SB, Brierley TT, Palanisamy N, Salusky IB, Goodman W, Brandi ML, Drueke TB, Sarfati E, Urena P, Chaganti RS, Pike JW, Arnold A 2000 Vitamin D receptor as a candidate tumor-suppressor gene in severe hyperparathyroidism of uremia. J Clin Endocrinol Metab 85:868-872.
19. Samander EH, Arnold A 2006 Mutational analysis of the vitamin D receptor does not support its candidacy as a tumor suppressor gene in parathyroid adenomas. J Clin Endocrinol Metab 91:5019-5021.
20. Perwad F, Zhang MY, Tenenhouse HS, Portale AA 2007 Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro. Am J Physiol Renal Physiol 293:F1577-F1583.
21. Usatfi M, Rousseau L, Demers C, Petit JL, Brossard JH, Gascon-Barre M, Lavigne JR, Zahradnik RJ, Nemeth EF, D'Amour P 2007 Parathyroid hormone fragments inhibit active hormone and hypocalcemia-induced 1,25(OH)2D synthesis. Kidney Int 72:1330-1335.